GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...

Endocrinologic and Metabolic Drugs Advisory Committee, the majority of panel members voted against the approval of sotagliflozin (Zynquista™) for use as an adjunct to insulin therapy for glycemic ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Diabetes is a condition that arises when proper blood sugar control has become defective. This leads to abnormally high blood sugar levels.

The combination of increased eating and weight loss particularly ... definitive answers about whether diabetes requires ...

The company's semaglutide injection—better known by the brand names Ozempic and Wegovy—has become well-known for its weight-loss results and ability to manage diabetes. And while there are several ...

The AYUSH ministry aims to combine traditional and modern medicine in order to make treatments more effective and improve patient outcomes ...

Ginger may contain beneficial components, including gingerols and shogaols. These compounds are thought to have antioxidant ...

While expected and seen as largely incremental, Jefferies analyst Peter Welford in a Tuesday note to investors said the detailed data for three early-stage assets support moving them into Phase IIb ...

Glucomannan: A soluble fiber derived from the root of the konjac plant, Glucomannan expands in the stomach, promoting a ...

Independent advisers to the U.S. Food and Drug Administration on Thursday voted against recommending Lexicon Pharmaceuticals' ...

Analyst Joseph Pantginis of H.C. Wainwright maintained a Buy rating on Biomea Fusion (BMEA – Research Report), retaining the price target ...